Literature DB >> 27354909

Lysergic acid diethylamide: a drug of 'use'?

Saibal Das1, Preeti Barnwal2, Anand Ramasamy3, Sumalya Sen4, Somnath Mondal5.   

Abstract

Lysergic acid diethylamide (LSD), described as a classical hallucinogen, began its journey from the middle of the last century following an accidental discovery. Since then, it was used as a popular and notorious substance of abuse in various parts of the world. Its beneficial role as an adjunct to psychotherapy was much unknown, until some 'benevolent' experiments were carried out over time to explore some of its potential uses. But, many of its effects were unclear and seemed to be a psychedelic enigma. In this review article, we have described the receptor pharmacology, mechanism of action, effects and adverse effects of LSD on the normal body system. We have also highlighted its addictive potentials and the chances of developing tolerance. We have assimilated some of the interesting therapeutic uses of this drug, such as an antianxiety agent, a creativity enhancer, a suggestibility enhancer, and a performance enhancer. We have also described LSD to be successfully used in drug and alcohol dependence, and as a part of psychedelic peak therapy in terminally ill patients. The relevant chronological history and literature in the light of present knowledge and scenarios have been discussed. Based on available evidence, LSD could be tried therapeutically in certain specific conditions under controlled settings. But as we mention, due to all the safety concerns, the use of this nonaddictive 'entheogen' in actual practice warrants a lot of expertise, caution, cooperation and ethical considerations.

Entities:  

Keywords:  abuse; addiction; dependency; hallucinogen; lysergic acid diethylamide; psychedelic

Year:  2016        PMID: 27354909      PMCID: PMC4910402          DOI: 10.1177/2045125316640440

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  121 in total

Review 1.  Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders.

Authors:  William R Miller; Paula L Wilbourne
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

2.  The psychedelic experience--a new concept in psychotherapy.

Authors:  J N SHERWOOD; M J STOLAROFF; W W HARMAN
Journal:  J Neuropsychiatr       Date:  1962 Nov-Dec

3.  Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

Authors:  Katherine A MacLean; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2011-09-28       Impact factor: 4.153

4.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

5.  LSD-assisted psychotherapy with terminal cancer patients.

Authors:  W N Pahnke; A A Kurland; L E Goodman; W A Richards
Journal:  Curr Psychiatr Ther       Date:  1969

6.  Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation.

Authors:  M Tomsovic; R V Edwards
Journal:  Q J Stud Alcohol       Date:  1970-12

7.  Long lasting effects of LSD on normals.

Authors:  W McGlothlin; S Cohen; M S McGlothlin
Journal:  Arch Gen Psychiatry       Date:  1967-11

8.  Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.

Authors:  Katja Ludewig; Mark A Geyer; Franz X Vollenweider
Journal:  Biol Psychiatry       Date:  2003-07-15       Impact factor: 13.382

9.  Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.

Authors:  W E Fantegrossi; J H Woods; G Winger
Journal:  Behav Pharmacol       Date:  2004-03       Impact factor: 2.293

10.  Effects of Schedule I drug laws on neuroscience research and treatment innovation.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-06-12       Impact factor: 34.870

View more
  5 in total

1.  Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Authors:  Kristóf János Bodnár; Péter Kakuk
Journal:  Med Health Care Philos       Date:  2019-06

2.  Potential of an Interactive Drug Prevention Mobile Phone App (Once Upon a High): Questionnaire Study Among Students.

Authors:  Máté Kapitány-Fövény; Eszter Vagdalt; Zsófia Ruttkay; Róbert Urbán; Mara J Richman; Zsolt Demetrovics
Journal:  JMIR Serious Games       Date:  2018-12-04       Impact factor: 4.143

3.  Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.

Authors:  Juan José Fuentes; Francina Fonseca; Matilde Elices; Magí Farré; Marta Torrens
Journal:  Front Psychiatry       Date:  2020-01-21       Impact factor: 4.157

Review 4.  Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Justin Grant; Amza Ali; Lorenzo Gordon; Wilfred Ngwa
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

Review 5.  Psychedelics: Their Limited Understanding and Future in the Treatment of Chronic Pain.

Authors:  Vedant N Hedau; Ashish P Anjankar
Journal:  Cureus       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.